Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use

Cytotherapy

Volumn 15, Issue 9, 2013, Pages 1086-1097

  Trojahn Kølle, Stig Frederik ^a   Oliveri, Roberto S ^a   Glovinski, Peter V ^a   Kirchhoff, Maria ^a   Mathiasen, Anders Bruun ^a   Elberg, Jens Jørgen ^a   Andersen, Peter Stemann ^a   Drzewiecki, Krzysztof Tadeusz ^a   Fischer Nielsen, Anne ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Adipose tissue derived stem cells; Chromosomal stability; Fetal bovine serum; Mesenchymal stromal cells; Pooled human platelet lysate

Indexed keywords

CELL SURFACE MARKER; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ARTICLE; CAPILLARY; CELL CULTURE; CELL EXPANSION; CELL LYSATE; CELL POPULATION; CELL POPULATION DOUBLING TIME; CELL PROLIFERATION; CELLULAR PARAMETERS; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE OPTIMIZATION; CULTURE TECHNIQUE; FEMALE; FETAL BOVINE SERUM; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; NONHUMAN; POOLED HUMAN PLATELET LYSATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; THROMBOCYTE;

BOVINAE;

ADIPOSE TISSUE-DERIVED STEM CELLS; CHROMOSOMAL STABILITY; FETAL BOVINE SERUM; MESENCHYMAL STROMAL CELLS; POOLED HUMAN PLATELET LYSATE;

ADIPOSE TISSUE; ANIMALS; BLOOD PLATELETS; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SERUM; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881102185     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.01.217     Document Type: Article

References (40)

1. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
2. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., et al. Precursors for fibroblasts indifferent populations of hematopoietic cells as detected bythe in vitro colony assay method. Exp Hematol 1974, 2:83-92.
3. Owen M., Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988, 136:42-60.
4. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
5. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
6. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
7. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
8. Krampera M., Pasini A., Pizzolo G., Cosmi L., Romagnani S., Annunziato F. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol 2006, 6:435-441.
9. Krampera M., Sartoris S., Liotta F., Pasini A., Angeli R., Cosmi L., et al. Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev 2007, 16:797-810.
10. Prockop D.J., Brenner M., Fibbe W.E., Horwitz E., Le B.K., Phinney D.G., et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010, 12:576-578.
11. Murohara T., Shintani S., Kondo K. Autologous adipose-derived regenerative cells for therapeutic angiogenesis. Curr Pharm Des 2009, 15:2784-2790.
12. Garcia-Olmo D., Herreros D., Pascual I., Pascual J.A., Del-Valle E., Zorrilla J., et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009, 52:79-86.
13. Haack-Sorensen M., Hansen S.K., Hansen L., Gaster M., Hyttel P., Ekblond A., et al. Mesenchymal stromal cell Phenotype is not influenced by confluence during culture expansion. Stem Cell Rev 2013, 9:44-58.
14. Qayyum A.A., Haack-Sorensen M., Mathiasen A.B., Jorgensen E., Ekblond A., Kastrup J. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med 2012, 7:421-428.
15. Kim M., Kim I., Lee S.K., Bang S.I., Lim S.Y. Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatol Surg 2011, 37:750-759.
16. Coleman S.R., Saboeiro A.P. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 2007, 119:775-785.
17. Sinna R., Delay E., Garson S., Delaporte T., Toussoun G. Breast fat grafting (lipomodelling) after extended latissimus dorsi flap breast reconstruction: a preliminary report of 200 consecutive cases. JPlast Reconstr Aesthet Surg 2010, 63:1769-1777.
18. Mathiasen A.B., Haack-Sorensen M., Kastrup J. Mesenchymal stromal cells for cardiovascular repair: current status and future challenges. Future Cardiol 2009, 5:605-617.
19. Liew A., O'Brien T. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther 2012, 3:28.
20. Boncoraglio G.B., Bersano A., Candelise L., Reynolds B.A., Parati E.A. Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev 2010, 9:CD007231.
21. Trojahn Kolle S.F., Oliveri R.S., Glovinski P.V., Elberg J.J., Fischer-Nielsen A., Drzewiecki K.T. Importance of mesenchymal stem cells in autologous fat grafting: a systematic review of existing studies. JPlast Surg Hand Surg 2012, 46:59-68.
22. Haack-Sorensen M., Friis T., Bindslev L., Mortensen S., Johnsen H.E., Kastrup J. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest 2008, 68:192-203.
23. Herve M.A., Buteau-Lozano H., Mourah S., Calvo F., Perrot-Applanat M. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. Exp Cell Res 2005, 309:24-31.
24. Shih D.T., Chen J.C., Chen W.Y., Kuo Y.P., Su C.Y., Burnouf T. Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 2011, 51:770-778.
25. Mackensen A., Drager R., Schlesier M., Mertelsmann R., Lindemann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 2000, 49:152-156.
26. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007, 47:1436-1446.
27. Vunjak-Novakovic G., Freshney R.I. Basic Principles of Cell Culture. Culture of Cells for Tissue Engineering 2006, Wiley, New York.
28. Naaijkens B.A., Niessen H.W., Prins H.J., Krijnen P.A., Kokhuis T.J., de J.N., et al. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res 2012, 348:119-130.
29. Blande I.S., Bassaneze V., Lavini-Ramos C., Fae K.C., Kalil J., Miyakawa A.A., et al. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 2009, 49:2680-2685.
30. Kocaoemer A., Kern S., Kluter H., Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007, 25:1270-1278.
31. Castegnaro S., Chieregato K., Maddalena M., Albiero E., Visco C., Madeo D., et al. Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissue. Curr Stem Cell Res Ther 2011, 6:105-114.
32. Cholewa D., Stiehl T., Schellenberg A., Bokermann G., Joussen S., Koch C., et al. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant 2011, 20:1409-1422.
33. Crespo-Diaz R., Behfar A., Butler G.W., Padley D.J., Sarr M.G., Bartunek J., et al. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 2011, 20:797-811.
34. Gottipamula S., Sharma A., Krishnamurthy S., Majumdar A.S., Seetharam R.N. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett 2012, 34:1367-1374.
35. Schallmoser K., Rohde E., Reinisch A., Bartmann C., Thaler D., Drexler C., et al. Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 2008, 14:185-196.
36. Mirabet V., Solves P., Minana M.D., Encabo A., Carbonell-Uberos F., Blanquer A., et al. Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank 2008, 9:1-10.
37. Dominici M., Le B.K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
38. Weibric G., Buch R.S., Kleis W.K., Hafner G., Hitzler W.E., Wagner W. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors 2002, 20:93-97.
39. Weibrich G., Kleis W.K., Hafner G., Hitzler W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. JCraniomaxillofac Surg 2002, 30:97-102.
40. Horn P., Bokermann G., Cholewa D., Bork S., Walenda T., Koch C., et al. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 2010, 12:888-898.